263 related articles for article (PubMed ID: 19602480)
1. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
3. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans.
Mondal AK; Das SK; Baldini G; Chu WS; Sharma NK; Hackney OG; Zhao J; Grant SF; Elbein SC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1450-7. PubMed ID: 20097709
[TBL] [Abstract][Full Text] [Related]
4. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.
Osmark P; Hansson O; Jonsson A; Rönn T; Groop L; Renström E
Diabetologia; 2009 May; 52(5):850-4. PubMed ID: 19247628
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
6. Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut.
Prokunina-Olsson L; Hall JL
Diabetologia; 2010 Apr; 53(4):712-6. PubMed ID: 20033802
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes.
Pang DX; Smith AJ; Humphries SE
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):550-6. PubMed ID: 22402060
[TBL] [Abstract][Full Text] [Related]
8. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
9. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population.
Chandak GR; Janipalli CS; Bhaskar S; Kulkarni SR; Mohankrishna P; Hattersley AT; Frayling TM; Yajnik CS
Diabetologia; 2007 Jan; 50(1):63-7. PubMed ID: 17093941
[TBL] [Abstract][Full Text] [Related]
10. TCF7L2 gene polymorphisms do not predict susceptibility to diabetes in tropical calcific pancreatitis but may interact with SPINK1 and CTSB mutations in predicting diabetes.
Mahurkar S; Bhaskar S; Reddy DN; Prakash S; Rao GV; Singh SP; Thomas V; Chandak GR
BMC Med Genet; 2008 Aug; 9():80. PubMed ID: 18706099
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
12. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
13. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
[TBL] [Abstract][Full Text] [Related]
14. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
Nordman S; Ostenson CG; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
[TBL] [Abstract][Full Text] [Related]
15. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study.
Stolerman ES; Manning AK; McAteer JB; Fox CS; Dupuis J; Meigs JB; Florez JC
Diabetologia; 2009 Apr; 52(4):614-20. PubMed ID: 19183934
[TBL] [Abstract][Full Text] [Related]
16. Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
Pradas-Juni M; Nicod N; Fernández-Rebollo E; Gomis R
Mol Endocrinol; 2014 Sep; 28(9):1558-70. PubMed ID: 25058603
[TBL] [Abstract][Full Text] [Related]
17. Effects of TCF7L2 polymorphisms on obesity in European populations.
Cauchi S; Choquet H; Gutiérrez-Aguilar R; Capel F; Grau K; Proença C; Dina C; Duval A; Balkau B; Marre M; Potoczna N; Langin D; Horber F; Sørensen TI; Charpentier G; Meyre D; Froguel P
Obesity (Silver Spring); 2008 Feb; 16(2):476-82. PubMed ID: 18239663
[TBL] [Abstract][Full Text] [Related]
18. Prime suspect: the TCF7L2 gene and type 2 diabetes risk.
Hattersley AT
J Clin Invest; 2007 Aug; 117(8):2077-9. PubMed ID: 17671643
[TBL] [Abstract][Full Text] [Related]
19. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
20. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population.
Alsmadi O; Al-Rubeaan K; Mohamed G; Alkayal F; Al-Saud H; Al-Saud NA; Al-Daghri N; Mohammad S; Meyer BF
BMC Med Genet; 2008 Jul; 9():72. PubMed ID: 18655717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
